Research examining GHK-Cu eye cream application in 41 women with mild to advanced photodamage over three months demonstrated reduced lines and wrinkles, improved skin density, and increased skin thickness superior to both placebo and vitamin K cream
Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028
T2D prevalence in sub-Saharan Africa has jumped from four million cases in 1980 to 23.6 million in 2021 and is projected to exceed 54 million by 2045 (3)
When taken as a supplement, glutathione must pass through multiple organs before it can be absorbed into the stream, meaning only a portion of its benefits reach the body
Read full disclaimer A GH-axis research bundle: one vial each of CJC-1295 (No DAC, 5mg) and Ipamorelin (5mg), a canonical secretagogue pairing for GH-axis studies
In the UK, the regulatory pathway for new medicines requires submission of a Marketing Authorisation Application (MAA) to the MHRA